Latest news

Closing ceremony for the 7th Reproductive Medicine Master's Degree by UA held at Instituto Bernabeu

  • 07/09/19

Students from the 7th Reproductive Medicine Master's Degree by University of Alicante (UA) and Instituto Bernabeu have concluded their 2018/2019 course with a closing ceremony held at the clinic's premises.

Read more

Instituto Bernabeu to gather worldwide reproductive medicine experts at the III International Meeting the Experts conference to be held in September

  • 07/02/19

Next September 2019 will see a number of renowned, worldwide experts in the different reproductive medicine areas meet at Instituto Bernabeu's III International Meeting the Experts conference. This triennial event is aimed at sharing new fertility related developments and knowledge with the purpose of attaining a renewed approach concerning the most important challenges facing reproductive medicine.

Read more

Instituto Bernabeu has participated in several expert congresses during the month of June

  • 06/20/19

Instituto Bernabeu undertakes vital healthcare work which is supplemented by its participation in congresses and both national and international events. One of this month's most relevant event took place in Cordoba. The 7th SEF National Meeting of Groups of Interest was held on 7th and 8th June. Every two years, the Spanish Fertility Society brings together experts in assisted reproductive medicine in order to share updated ideas and make new contributions across various fields.

Read more

The PGT-A test performed by the Instituto Bernabeu genetics laboratory is awarded the highest possible mark by a European evaluator

  • 06/18/19

The genetics laboratory at Instituto Bernabeu has been awarded the highest possible mark in an assessment of its PGT-A genetics test by an external and independent European organism. The assessment was performed anonymously on 56 European laboratories. The PGT-A test assesses if the embryo is chromosomally normal or aneuploidy. It is recommended for women who are older when having children; women who have a background of recurrent pregnancy loss; and women who have suffered from implantation failure. This test is also recommended for couples who have chromosomal abnormalities.

Read more